Skip to main content

Scaling-Up and Production of Therapeutic Antibodies for Preclinical Studies

  • Protocol
  • First Online:
Therapeutic Antibodies

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 525))

Abstract

Monoclonal antibodies are increasingly used for treatment of various diseases, mostly cancer therapy and auto-immune diseases. New chimeric, humanized, or fully-human antibodies specific to novel or already validated targets are being developed in many academic labs as well as in commercial entities. A validation of antibodies in preclinical settings is an important component of the road from discovery to clinic. Preparing sufficient amount of high-quality antibodies for preclinical studies is a challenge in some cases. This article summarizes protocols used in research laboratories, and is based on our own experience in the establishment of stable clones of CHO cells to scaling-up of tissue cultures for production of antibodies in bioreactors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Ab:

antibody

IgG:

immunoglobulin

Fab:

antigen-binding fragment

CDR:

complementarity-determining regions

CHO:

Chinese hamster ovary

HRP:

horseradish peroxidase

References

  1. Johansson, D. X., Drakenberg, K., Hopmann, K. H., Schmidt, A., Yari, F., Hinkula, J., and Persson, M. A. (2007) Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells. J. Immunol. Methods 318:37–46.

    Article  PubMed  CAS  Google Scholar 

  2. Zhu, L., van de Lavoir, M. C., Albanese, J., Beenhouwer, D. O., Cardarelli, P. M., Cuison, S., Deng, D. F., Deshpande, S., Diamond, J. H., Green, L., Halk, E. L., Heyer, B. S., Kay, R. M., Kerchner, A., Leighton, P. A., Mather, C. M., Morrison, S. L., Nikolov, Z. L., Passmore, D. B., Pradas-Monne, A., Preston, B. T., Rangan, V. S., Shi, M., Srinivasan, M., White, S. G., Winters-Digiacinto, P., Wong, S., Zhou, W., and Etches, R. J. (2005) Production of human monoclonal antibody in eggs of chimeric chickens. Nat. Biotechnol. 23:1159–69.

    Article  PubMed  CAS  Google Scholar 

  3. Werner, R. G., Noe, W., Kopp, K., and Schluter, M. (1998) Appropriate mammalian expression systems for biopharmaceuticals. Arzneimittelforschung 48:870–80.

    PubMed  CAS  Google Scholar 

  4. Bender, E., Woof, J. M., Atkin, J. D., Barker, M. D., Bebbington, C. R., and Burton, D. R. (1993) Recombinant human antibodies: linkage of a Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. Hum. Antibodies Hybridomas 4:74–9.

    PubMed  CAS  Google Scholar 

  5. Li, J., Menzel, C., Meier, D., Zhang, C., Dubel, S., and Jostock, T. (2007) A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. J. Immunol. Methods 318:113–24.

    Article  PubMed  CAS  Google Scholar 

  6. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W., Sawyer, L. S., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024–7.

    Article  PubMed  CAS  Google Scholar 

  7. Zhang, M. X., Bohlman, M. C., Itatani, C., Burton, D. R., Parren, P. W., St Jeor, S. C., and Kozel, T. R. (2006) Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect. Immun. 74:362–9.

    Article  PubMed  CAS  Google Scholar 

  8. Wurm, F. M. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22:1393–8.

    Article  PubMed  CAS  Google Scholar 

  9. Remaut, K., Sanders, N. N., Fayazpour, F., Demeester, J., and De Smedt, S. C. (2006) Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J. Control Release 115:335–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the Intramural research Program of the NIH, NCI, Center for Cancer Research.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Feng, Y., Dimitrov, D.S. (2009). Scaling-Up and Production of Therapeutic Antibodies for Preclinical Studies. In: Dimitrov, A. (eds) Therapeutic Antibodies. Methods in Molecular Biology™, vol 525. Humana Press. https://doi.org/10.1007/978-1-59745-554-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-554-1_26

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-92-3

  • Online ISBN: 978-1-59745-554-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics